A recent study indicates that individuals who stop using popular GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who end conventional lifestyle programs.
Research printed in a prominent medical journal points out that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Users using such drugs must be informed of the potential of quick weight regain when the medication ends," warns expert Dr. Susan Jebb.
That rate of regain suggests a reversion to starting weight in about one and a half years.
Weighing Approaches
The analysis, which reviewed 37 of studies involving thousands of patients, compared the effects of these new drugs with other pills.
Scientists note that individuals who shed pounds through dieting typically have a less rapid weight regain—around 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Nutrition scientists propose the way of the jabs explains the accelerated weight return.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels several times higher than normal may cause the system to produce less of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement results in appetite is unsuppressed, making overeating far more likely."
A Chronic Disease?
The NHS recommend the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, considering the significant potential of relapse, the treatment is often ongoing.
This opinion is reinforced by drug manufacturers, who state that the results "underscore the chronic character of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have discontinued the medication explain a intense return of hunger.
"It felt as if a switch activating and you become ravenous," recalled one woman.
The struggle is exacerbated if patients have not developed lasting dietary or behavioural modifications during treatment.
Growing Interest
Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with desire continuing to grow.
- Use is higher among women than males.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while the jabs are effective agents for weight loss, they are not a standalone solution and long-term success relies on integrated lifestyle support.
